Medication event monitoring system

Matsui D, Hermann C, Braudo M et al (1992) Clinical use of the Medication Event Monitoring System a new window into pediatric compliance. Clin Pharmacol Ther 52 102-3. 

Patients should always start with the lowest recommended dose and increase slowly to avoid overdosing. Follow-up with the patient is necessary to evaluate whether the dietary supplement is safe and effective. Report any suspected adverse event to FDA s Medwatch, 1-800-FDA-1088. FDA has developed the Special Nutritionals Adverse Event Monitoring System (SN/AEMS), a database of adverse events associated with the use of special nutritional products dietary supplements, infant formulas, and medical foods. ... 

MedWatch program. The FDA recently established the Special Nutritionals Adverse Event Monitoring System, a searchable database including information about suspected adverse events associated with dietary supplements or nutritional products. This database includes reports that have been submitted to MedWatch and can be accessed via the Internet (http //vm.cfsan.fda.gov/ dms/ aems.html). Continued efforts by health-care professionals to recognize and report suspected interactions between prescription medications and herbal and other alternative therapies should ultimately increase knowledge and awareness of interactions and improve the quality of patient care (see Heck et al., 2000 Izzo, 2004 Butterweck, 2004 Chan, 2005). 

Because nearly 70% of patients who use alternative therapies do not inform their health-care providers about these products, pharmacists and other health-care professionals should question all patients about their use of alternative therapies. Health-care professionals should remain vigilant for potential interactions between alternative therapies and prescription medications, especially medications with a narrow therapeutic index, and should report suspected interactions to the FDA MedWatch program. The FDA recently established the Special Nutritionals Adverse Event Monitoring System, a searchable database including information about... 

The medication use process is a complex system intended to optimize patient outcomes within organizational constraints. Quality medication use involves selection of the optimal drug, avoidance of adverse medication events, and completion of the therapeutic objective. Safe medication practices focus on the avoidance of medication errors. Medication use review and ongoing medication monitoring activities focus on optimizing medication selection and use. These two approaches are important means of assessing and optimizing the quality of medication use. 

The growth of the aging population, regulatory overview and increased business opportunities will ensure the growth of clinical research in the elderly. Recent reports of the high level of seniors adverse events, many leading to deaths, both in and outside hospitals, will force more monitoring systems for medications. Soon, plastic medicine card chips with imprinted medication recorded by the pharmacist will be required by third-party insurers. This would ensure that all current concurrent medications are captured. 

This organization was founded in 1989 to monitor anesthesia errors and was expanded to patient incident reporting and monitoring after the findings of the Quality in Australian Health Care Study (QAHCS) in 1995 [9]. Adverse medical events are reported and analyzed through its subsidiary known as Patient Safety International (PSI), using the Advanced Incident Management System (AIMS), a software tool. 

Public health surveillance, the first component of the template, should operate continuously to improve the chances for the quick detection of unusual medical events in the local population. As part of the medical surveillance systems, several communities are currently monitoring hospital admissions, 911 calls, and unexplained deaths. Once an anomaly is detected, a medical diagnosis must be made to identify and confirm its cause. If a specific disease is confirmed, the public health community will most likely undertake an epidemiological investigation to determine the disffibution of cases and the source or sources of the outbreak. 

To ensure that an operation is under control may necessitate atmospheric monitoring this is summarized in Chapter 9. General safety considerations, administration and systems of work requirements, including elementary first aid, are summarized in Chapter 11. For example, the recommended strategy is to include provision for appropriate first aid procedures within the system of work before specific chemicals are brought into use to so order work practices that the risk of exposure is minimized and in the event of an accident involving any but the most trivial injuries — with no foreseeable likelihood of complications or deterioration — to seek immediate medical assistance. 

The Important Role of Pharmacists in a Complex Risk-Management System Managing the Risks from Medical Product Use by Focusing on Patient Education, Monitoring, and Adverse Event Reporting... 

The lOM report concludes that most of these errors are the result of systemic problems rather than poor performance by individual providers. Pharmacists play a key role in helping prevent and eliminate medication errors by providing information on the proper use of medications. Pharmacists provide the link between prescribers and patients, as shown in Figure 27.1, and can monitor for medication errors and adverse events. 

A medication error is any preventable event that may cause or lead to inappropriate medication use or patient harm, while the medication is in the control of the health care professional, patient, or consumer. Such events may be related to professional practice, health care products, procedures, and systems including prescribing order communication product labeling, packaging, and nomenclature compounding dispensing distribution administration education monitoring and use. 

---